Skip to main content

Lead, Whole Blood (Maternal)

CPT 83655

Test Details

Methodology

Atomic absorption spectrometry (AAS) or inductively coupled plasma/mass spectrometry (ICP/MS)

Result Turnaround Time

2 - 4 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Use

Monitor maternal blood for environmental lead exposure. The Centers for Disease Control and Prevention recommends the following testing schedule for frequency of maternal blood lead follow-up during pregnancy.1 See table.

Result of Screening Test

Perform Diagnostic Test on Venous Blood

<5 μg/dL

No follow-up is indicated.

5−14 μg/dL

Within one month. Obtain a maternal BLL or cord BLL at delivery.

15−24 μg/dL

Within one month and then every two to three months. Obtain a maternal BLL or cord BLL at delivery.

25−44 μg/dL

Within one to four weeks and then every month. Obtain a maternal BLL or cord BLL at delivery. Within 24 hours and then at frequent intervals depending on clinical interventions and trends in BLL. Consultation with a clinician experienced in the management of pregnant women with BLLs in this range is strongly advised. Obtain a maternal BLL or cord BLL at delivery.

Limitations

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen Requirements

Specimen

Whole blood

Volume

3 mL

Minimum Volume

0.5 mL

Container

Royal blue-top (EDTA) tube or tan-top lead-free tube; submit original unopened tube

Collection Instructions

Mix blood thoroughly to avoid clotting.

Stability Requirements

Temperature

Period

Room temperature

14 days

Refrigerated

14 days

Frozen

14 days

Freeze/thaw cycles

Stable x2

Storage Instructions

Maintain specimen at room temperature.

Causes for Rejection

Clotted specimen

Footnotes

1. Ettinger AS, Wengrovitz AG, eds. Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating Women. Atlanta, Ga: Centers for Disease Control and Prevention, US Department of Health and Human Services; November 2010.

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
700433 Lead, Maternal Blood 77307-7 700440 Lead, Blood (Maternal) ug/dL 77307-7
Order Code700433
Order Code NameLead, Maternal Blood
Order Loinc77307-7
Result Code700440
Result Code NameLead, Blood (Maternal)
UofMug/dL
Result LOINC77307-7